C4U Overview
- Year Founded
-
2018

- Status
-
Private
- Employees
-
17

- Latest Deal Type
-
2ndary - Private
- Investors
-
6
C4U General Information
Description
Developer of a genome editing technology designed to become a platform for drug discovery support business. The company's technology focuses on CRISPR or Cas3 genome editing method tools to develop basic technologies to serve various industries, enabling pharmaceutical companies to develop new gene therapy methods for various intractable diseases.
Contact Information
Website
www.crispr4u.jpCorporate Office
- 2-8 Yamadaoka
- Osaka University Suita Campus Techno Alliance C Building 7F
- Suita, Osaka 565-0871
- Japan
Corporate Office
- 2-8 Yamadaoka
- Osaka University Suita Campus Techno Alliance C Building 7F
- Suita, Osaka 565-0871
- Japan
C4U Timeline
C4U Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
6. Secondary Transaction - Private | Completed | Pre-Clinical Trials | ||||
5. Later Stage VC (Series B) | 17-May-2023 | Completed | Pre-Clinical Trials | |||
4. Accelerator/Incubator | 01-Jan-2022 | Completed | Startup | |||
3. Early Stage VC (Series A) | 04-Aug-2021 | Completed | Pre-Clinical Trials | |||
2. Seed Round | 11-Mar-2019 | $676K | $1.44M | Completed | Pre-Clinical Trials | |
1. Seed Round | 21-Aug-2018 | $766K | $766K | Completed | Pre-Clinical Trials |
C4U Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
A Preferred | ||||||||
Ordinary Shares | ||||||||
Ordinary Shares | 120 | $4629.75 | $4629.75 | 1x | $4629.75 | 4% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
C4U Patents
C4U Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2022229417-A1 | Cas3 protein | Pending | 01-Mar-2021 | ||
CA-3210100-A1 | Methods for producing cas3 proteins | Pending | 01-Mar-2021 | ||
AU-2022229417-A9 | Cas3 protein | Pending | 01-Mar-2021 | ||
US-20240141310-A1 | Methods for producing cas3 proteins | Pending | 01-Mar-2021 | ||
EP-4303310-A1 | Method for producing cas3 protein | Pending | 01-Mar-2021 | C12N9/22 |
C4U Signals
C4U Investors (6)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
JIC Venture Growth Investments | Venture Capital | Minority | ||
Mitsubishi UFJ Capital | Venture Capital | Minority | ||
Nissay Capital | Venture Capital | Minority | ||
Japan External Trade Organization | Government | |||
DCI Partners | Venture Capital | Minority |
C4U FAQs
-
When was C4U founded?
C4U was founded in 2018.
-
Where is C4U headquartered?
C4U is headquartered in Suita, Japan.
-
What is the size of C4U?
C4U has 17 total employees.
-
What industry is C4U in?
C4U’s primary industry is Discovery Tools (Healthcare).
-
Is C4U a private or public company?
C4U is a Private company.
-
What is C4U’s current revenue?
The current revenue for C4U is
. -
How much funding has C4U raised over time?
C4U has raised $21.1M.
-
Who are C4U’s investors?
JIC Venture Growth Investments, Mitsubishi UFJ Capital, Nissay Capital, Japan External Trade Organization, and DCI Partners are 5 of 6 investors who have invested in C4U.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »